Gabriela Gruia - May 5, 2023 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John Hamill, Attorney-in-fact
Stock symbol
APRE
Transactions as of
May 5, 2023
Transactions value $
$0
Form type
4
Date filed
5/8/2023, 05:17 PM
Previous filing
Jun 6, 2022
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APRE Stock Options (Right to Buy) Award $0 +12.5K $0.00 12.5K May 5, 2023 Common Stock 12.5K $3.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options shall vest in full on May 5, 2024, subject to the reporting person's continued service through and including the applicable vesting date.